BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND MLH1, COCA2, 4292, ENSG00000076242, hMLH1, FCC2, HNPCC2, P40692, MGC5172, HNPCC AND Treatment
93 results:

  • 1. The relationship between DNA mismatch repair gene and other prognostic parameters in pancreatic adenocarcinoma.
    Urganci N; Kepil N; Ergun S; Bakkaloglu OK
    J Surg Oncol; 2024 Apr; 129(5):876-884. PubMed ID: 38173349
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Expression of EGFR, PD-L1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high-grade serous tubo-ovarian carcinoma.
    Nikas IP; Park SY; Song MJ; Lee C; Ryu HS
    Diagn Cytopathol; 2024 Feb; 52(2):69-75. PubMed ID: 37937321
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Case report: Remarkable response to a novel combination of mitotane, etoposide, paraplatin, and sintilimab in a patient with metastatic adrenocortical carcinoma.
    Weng Y; Wang L; Wang XY; Fan XX; Yan L; Li ZH; Zhang SL
    Front Endocrinol (Lausanne); 2023; 14():1115893. PubMed ID: 37745701
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection.
    Lim DH; Yoon H; Kim KP; Ryoo BY; Lee SS; Park DH; Song TJ; Hwang DW; Lee JH; Song KB; Kim SC; Hong SM; Hyung J; Yoo C
    Cancer Res Treat; 2023 Oct; 55(4):1313-1320. PubMed ID: 37139665
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer.
    Rigter LS; Snaebjornsson P; Rosenberg EH; Altena E; van Grieken NCT; Aleman BMP; Kerst JM; Morton L; Schaapveld M; Meijer GA; van Leeuwen FE; van Leerdam ME;
    PLoS One; 2022; 17(7):e0270591. PubMed ID: 35877698
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance.
    Hamblin R; Vardon A; Akpalu J; Tampourlou M; Spiliotis I; Sbardella E; Lynch J; Shankaran V; Mavilakandy A; Gagliardi I; Meade S; Hobbs C; Cameron A; Levy MJ; Ayuk J; Grossman A; Ambrosio MR; Zatelli MC; Reddy N; Bradley K; Murray RD; Pal A; Karavitaki N
    Lancet Diabetes Endocrinol; 2022 Aug; 10(8):581-588. PubMed ID: 35780804
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Complete Response of a Patient With a Mismatch Repair Deficient Aggressive Pituitary Adenoma to Immune Checkpoint Inhibitor Therapy: A Case Report.
    Shah S; Manzoor S; Rothman Y; Hagen M; Pater L; Golnik K; Mahammedi A; Lin AL; Bhabhra R; Forbes JA; Sengupta S
    Neurosurgery; 2022 Aug; 91(2):e51-e56. PubMed ID: 35544035
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The clinical features and management of Lynch syndrome-associated ovarian cancer.
    Ran X; Jing H; Li Z
    J Obstet Gynaecol Res; 2022 Jul; 48(7):1538-1545. PubMed ID: 35478369
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.
    Qiao PP; Tian KS; Han LT; Ma B; Shen CK; Zhao RY; Zhang Y; Wei WJ; Chen XP
    Endocrine; 2022 Jun; 76(3):660-670. PubMed ID: 35366156
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pancreatic cancer with Mutation in BRCA1/2, mlh1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
    Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Lynch syndrome-associated epithelial ovarian cancer and its immunological profile.
    Rasmussen M; Lim K; Rambech E; Andersen MH; Svane IM; Andersen O; Jensen LH; Nilbert M; Therkildsen C
    Gynecol Oncol; 2021 Sep; 162(3):686-693. PubMed ID: 34275654
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A correlation study of mismatch repair immunohistochemical protein expression of pancreatic solid tumors in cytology cell blocks and matching surgical specimens.
    Teodosescu A; Chan I; Elder J; Wu M
    Diagn Cytopathol; 2021 Jun; 49(6):700-705. PubMed ID: 33615705
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast cancer or Ovarian cancer, 2012-2019.
    Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
    J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid cancer: The Influence of DNA Repair Genes Variants.
    S Santos L; M Gil O; N Silva S; C Gomes B; C Ferreira T; Limbert E; Rueff J
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32957448
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Diffuse Intratumoral Stromal Inflammation in Ovarian Clear Cell Carcinoma is Associated With Loss of Mismatch Repair Protein and High PD-L1 Expression.
    Lin SY; Hang JF; Lin YY; Lai CR; Ho HL; Chou TY
    Int J Gynecol Pathol; 2021 Mar; 40(2):148-155. PubMed ID: 32897958
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Exceptional Response to A Single Cycle of Immunotherapy in a Lynch Syndrome Patient with Metastatic Pancreatic Adenocarcinoma.
    Patil NR; Khan GN
    Am J Case Rep; 2020 Jul; 21():e923803. PubMed ID: 32658872
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The utility of immunohistochemical testing for mismatch repair proteins in fine needle aspiration specimens of pancreatic adenocarcinoma.
    Mettman D; Haer E; Olyaee M; Rastogi A; Madan R; O'Neil M; Kelting S; Dennis K; Fan F
    Ann Diagn Pathol; 2020 Aug; 47():151552. PubMed ID: 32570025
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Negative prognostic impact of PD-L1 expression in tumor cells of undifferentiated (anaplastic) carcinoma with osteoclast-like giant cells of the pancreas: study of 13 cases comparing ductal pancreatic carcinoma and review of the literature.
    Hrudka J; Lawrie K; Waldauf P; Ciprová V; Moravcová J; Matěj R
    Virchows Arch; 2020 Nov; 477(5):687-696. PubMed ID: 32424767
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Metastatic rectal cancer to papillary thyroid carcinoma: a case report and review of literature.
    Luo M; Huang Y; Li Y; Zhang Y
    BMC Gastroenterol; 2020 May; 20(1):136. PubMed ID: 32375670
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Frequency of mismatch repair deficiency in pancreatic ductal adenocarcinoma.
    Ahmad-Nielsen SA; Bruun Nielsen MF; Mortensen MB; Detlefsen S
    Pathol Res Pract; 2020 Jun; 216(6):152985. PubMed ID: 32360245
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.